ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jul 9, 2012
Informatica Lowers Guidance Again
Data software solutions provider Informatica lowered its second-quarter guidance for the second time this year. Shares continue to fall.
Jul 9, 2012
Seagate Warns About Revenue and Earnings
Hard-drive storage manufacturer Seagate Technology will not meet its own expectations. The industry continues to recover from the flooding in Thailand.
Jul 7, 2012
Can Navistar Make a Comeback?
Truck maker Navistar announced that it is ditching its diesel engine that failed to receive US regulatory approval in favor of a new one. The shares have fallen below the low end of our fair value range, but we're not ready to pull the trigger anytime soon.
Jul 6, 2012
AutoNation and Volkswagen Report Good News
Car dealer AutoNation reported fantastic results for June and its second quarter. German auto manufacturer Volkswagen will finally acquire the rest of Porsche.
Jul 6, 2012
International Speedway Posts Solid Results
The NASCAR racetrack owner posted strong results Thursday. The firm's middle class consumer is returning slowly.
Jul 5, 2012
June Same Store Sales Actually Weren’t Bad
Though a few companies fell short of expectations, we thought June same-store sales numbers were mostly positive. We think lower energy prices may have reinvigorated the US consumer during the month.
Jul 4, 2012
Strong Auto Sales Continue in June
Sales in the US remained strong throughout June. We think SAAR will remain above 14 million units for the remainder of 2012.
Jul 3, 2012
Ancestry.com's Subscriber Growth Remains Strong
The online genealogy firm said that it added its 2 millionth active subscriber recently. We continue to expect ongoing subscriber expansion thanks to the release and digital indexing of the 1940 US Federal Census.
Jul 2, 2012
Bristol-Myers Squibb and AstraZeneca Purchase Amylin
The two pharmaceutical companies will collaborate to commercialize the diabetes portfolio of Amylin. We think the deal is value neutral.
Jul 1, 2012
Valuentum's July Edition of Its Dividend Growth Newsletter!
The July edition of our Dividend Growth Newsletter is now available.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.